Prof. Dr. Efnan Algın

First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis

Medicina, 2026

DOI 10.3390/medicina62050984 PMID 42195237 Açık erişimli tam metinKaynak: OpenAlex

Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15041657 PMID 41753346 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Clinicopathological Features of Intrahepatic Cholangiocarcinoma with Assessment of IDH1 Mutation: A Two-Center Retrospective Study

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15135290 PMID 42452749 Açık erişimli tam metinKaynak: ORCID

A Machine Learning Framework for Prognostic Modeling in Stage III Colon Cancer

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15083091 PMID 42074893 Açık erişimli tam metinKaynak: ORCID

Association of endoscopic and CT response with pathological response after preoperative FLOT-based therapy for gastric and gastroesophageal junction cancer: a retrospective cohort study

Frontiers in Oncology, 2026

DOI 10.3389/fonc.2026.1960800 PMID 42964134 Açık erişimli tam metinKaynak: OpenAlex

Abiraterone Acetate Plus Prednisone Induced Bilateral Avascular Necrosis of the Femoral Head

Journal of Oncological Sciences, 2026

DOI 10.37047/jos.galenos.2025.2025-7-5 Açık erişimli tam metinKaynak: OpenAlex

Prognostic Value of the Lung Immune Prognostic Index in Metastatic Renal Cell Carcinoma Treated With Second-Line Immunotherapy

International journal of urology : official journal of the Japanese Urological Association, 2026

DOI 10.1111/iju.70619 PMID 42655932 Açık erişimli tam metinKaynak: Europe PMC

Low muscle mass predicts poor response to neoadjuvant chemotherapy in advanced ovarian cancer

Journal of ovarian research, 2026

DOI 10.1186/s13048-025-01960-4 PMID 42298636 Açık erişimli tam metinKaynak: Europe PMC

Prognostic value of the glucose-to-lymphocyte ratio in surgically treated endometrial cancer: a retrospective cohort study

Future Oncology, 2026

DOI 10.1080/14796694.2026.2622299 PMID 41607196 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Neoadjuvant chemotherapy with surgery versus concurrent chemoradiation in N2 non-small cell lung cancer: a retrospective comparative analysis of treatment outcomes

Turkish Journal of Clinics and Laboratory, 2026

DOI 10.18663/tjcl.1837114 Açık erişimli tam metinKaynak: OpenAlex

CANT1 as a novel prognostic biomarker in triple‑negative breast cancer

Oncology Letters, 2026

DOI 10.3892/ol.2026.15519 PMID 41858377 Açık erişimli tam metinKaynak: OpenAlex

Prognostic ımpact of the modified Ryan tumor regression score in gastric and GEJ adenocarcinomas treated with neoadjuvant FLOT regimen

Clinical & Translational Oncology, 2026

DOI 10.1007/s12094-026-04309-5 PMID 41851551 Kaynak: OpenAlex

Machine learning–based prediction of recurrence after curative resection in non–small cell lung cancer

Scientific Reports, 2026

DOI 10.1038/s41598-026-47862-3 PMID 41957214 Açık erişimli tam metinKaynak: OpenAlex

Long-term Outcomes and Prognostic Factors in Chordoma: A 20-year Single-center Experience

Journal of Oncological Sciences, 2026

DOI 10.37047/jos.galenos.2026.2025-11-6 Açık erişimli tam metinKaynak: OpenAlex

Prediction of postoperative recurrence in non–small cell lung cancer using machine learning approaches.

Journal of Clinical Oncology, 2026

DOI 10.1200/jco.2026.44.16_suppl.e20020 Kaynak: OpenAlex

Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group

BMC Cancer, 2026

DOI 10.1186/s12885-026-16667-y PMID 42693417 Açık erişimli tam metinKaynak: OpenAlex

Prognostic Value of Baseline Metabolic Tumor Volume on [18F]FDG PET/CT in Metastatic Breast Cancer Treated With CDK4/6 Inhibitors

Clinical Breast Cancer, 2026

DOI 10.1016/j.clbc.2026.09.009 PMID 42879936 Kaynak: OpenAlex

Adjuvant Docetaxel–Cyclophosphamide Versus Anthracycline–Taxane Chemotherapy in Stage I–III HR-Positive/HER2-Negative Breast Cancer: A Real-World Propensity Score Overlap-Weighted Cohort Study

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15218568 Açık erişimli tam metinKaynak: OpenAlex

Elderly Men with De Novo Metastatic Castration-Sensitive Prostate Cancer: Therapy and Does Comorbidity Matter

Medicina, 2025

DOI 10.3390/medicina61112068 PMID 41303903 Açık erişimli tam metinKaynak: ORCID

Anorectal Malignant Melanoma: Diagnostic Pitfalls and Prognostic Insights from a Single-Center Retrospective Analysis

Diagnostics, 2025

DOI 10.3390/diagnostics15162086 PMID 40870938 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Prognostic Factors and Long-Term Survival in Kaposi’s Sarcoma Patients: Results from a 28-Year Retrospective Cohort

Medicina, 2025

DOI 10.3390/medicina61040724 PMID 40283016 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

A New Prognostic Indicator for Biliary Tract Cancers: The ABIC Score

Current Oncology, 2025

DOI 10.3390/curroncol32040200 PMID 40277757 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Clinicopathologic Disease Characteristics and Their Association with Adjuvant Chemotherapy Outcomes in Pulmonary Large-Cell Carcinoma Patients with or Without Neuroendocrine Features

Diagnostics (Basel, Switzerland), 2025

DOI 10.3390/diagnostics15202582 PMID 41153253 Açık erişimli tam metinKaynak: Europe PMC

2792TiP A phase Ib/II study of gocatamig (MK-6070; HPN328) and ifinatamab deruxtecan for relapsed/refractory extensive-stage small cell lung cancer (ES-SCLC)

Annals of Oncology, 2025

DOI 10.1016/j.annonc.2025.08.3403 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab

Radiology and Oncology, 2025

DOI 10.2478/raon-2025-0065 PMID 41401058 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Survival advantage of bevacizumab rechallenge in recurrent ovarian cancer regardless of platinum sensitivity

Anti-Cancer Drugs, 2025

DOI 10.1097/cad.0000000000001798 PMID 41430637 1 atıf (OpenAlex) Kaynak: OpenAlex

When location meets biology: combined risk patterns drive outcomes in primary central nervous system lymphoma

Turkish Journal of Clinics and Laboratory, 2025

DOI 10.18663/tjcl.1761637 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Palliative Radiotherapy in Metastatic Breast Cancer Patients on CDK4/6 Inhibitors: Safety Analysis

Cancers, 2025

DOI 10.3390/cancers17030424 PMID 39941794 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

The Effect of Positron Emission Tomography-Computed Tomography Parameters on Pathological Response in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Treatment

Oncology Research and Treatment, 2025

DOI 10.1159/000545820 PMID 40209694 Kaynak: OpenAlex

CDK4-6 Inhibitors: Evaluation of Efficacy in Cases of Hormone Receptor-Positive HER2-Negative Breast Cancer with Only Bone Metastasis

Journal of Oncological Sciences, 2025

DOI 10.37047/jos.galenos.2024.2024.103871 Açık erişimli tam metinKaynak: OpenAlex

Clinicopathological Features and Treatment Outcomes of Gestational Trophoblastic Disease: A Retrospective Study From A Tertiary Care Center in Türkiye

Ankara City Hospital Medical Journal, 2025

DOI 10.5505/achmedj.2025.25633 Açık erişimli tam metinKaynak: OpenAlex

Association of Microsatellite Instability with Pro-inflammatory Markers and Survival in Patients with Endometrial Cancer

Journal of Oncological Sciences, 2025

DOI 10.37047/jos.galenos.2025.2025-3-12 Açık erişimli tam metinKaynak: OpenAlex

Is maintenance chemotherapy always necessary in gestational trophoblastic neoplasia? A retrospective cohort analysis

The European Research Journal, 2025

DOI 10.18621/eurj.1754019 Açık erişimli tam metinKaynak: OpenAlex

Risk-Based Evaluation of Adjuvant Chemotherapy in Stage I Epithelial Ovarian Cancer: A Retrospective Cohort Study

Acta haematologica oncologica Turcica., 2025

DOI 10.4274/ahot.galenos.2025.2025-6-8 Açık erişimli tam metinKaynak: OpenAlex

Prognostic impact of hand-foot skin reaction in regorafenib-treated adult-type diffuse gliomas: A multicenter Turkish Oncology Group study

Scientific Reports, 2025

DOI 10.1038/s41598-025-19899-3 PMID 41102268 Açık erişimli tam metinKaynak: OpenAlex

Comparison of the Efficacy of First-Line Pemetrexed-Platinum and Gemcitabine-Platinum Regimens in Malignant Peritoneal Mesothelioma

Clinical Medicine Insights Oncology, 2025

DOI 10.1177/11795549251385075 PMID 41133016 Açık erişimli tam metinKaynak: OpenAlex

649eP Real-world survival outcomes in metastatic lobular breast cancer treated with CDK4/6 inhibitors and endocrine therapy: A multicenter retrospective study

Annals of Oncology, 2025

DOI 10.1016/j.annonc.2025.08.1069 Açık erişimli tam metinKaynak: OpenAlex

Real-world treatment patterns and prognostic indicators in upper tract urothelial carcinoma: A Turkish Oncology Group (TOG) study

European Urology Open Science, 2025

DOI 10.1016/s2666-1683(25)01751-3 Açık erişimli tam metinKaynak: OpenAlex

The Impact of Sodium on Prognosis in RCC and NSCLC Patients Receiving Second-line Nivolumab Treatment

Journal of Oncological Sciences, 2025

DOI 10.37047/jos.galenos.2025.2025-8-12 Açık erişimli tam metinKaynak: OpenAlex

Comparative Outcomes of Surgery and Chemoradiotherapy After Neoadjuvant Chemotherapy in Stage II–III Bladder Cancer

The European Research Journal, 2025

DOI 10.18621/eurj.1807684 Açık erişimli tam metinKaynak: OpenAlex

Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer

BMC Cancer, 2024

DOI 10.1186/s12885-023-11783-5 PMID 38166764 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

A propensity score‐matched comparison of neoadjuvant chemoradiotherapy with cisplatin‐ 5FU and carboplatin–paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study

Cancer Medicine, 2024

DOI 10.1002/cam4.70002 PMID 39030808 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma

Journal of Chemotherapy, 2024

DOI 10.1080/1120009x.2024.2403051 PMID 39257075 2 atıf (Europe PMC) Kaynak: OpenAlex

Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group

International Journal of Gynecological Cancer, 2024

DOI 10.1136/ijgc-2024-005419 PMID 38950923 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

Refractory hypoglycemia is sensitive to octreotide therapy: is it triggered by sorafenib or hepatocellular carcinoma?

Anti-Cancer Drugs, 2024

DOI 10.1097/cad.0000000000001669 PMID 39625742 2 atıf (OpenAlex) Kaynak: OpenAlex

The efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: A multicenter study by the Turkish Oncology Group (TOG).

Journal of Clinical Oncology, 2024

DOI 10.1200/jco.2024.42.16_suppl.e17534 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights From a Multi-Center Study

Annals of Surgical Oncology, 2024

DOI 10.1245/s10434-024-15506-3 PMID 38806763 11 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Impact of 68 Ga-PSMA PET/CT on Survival and Management in Prostate Cancer

Current Medical Imaging Formerly Current Medical Imaging Reviews, 2024

DOI 10.2174/0115734056276494231207101146 PMID 38284703 3 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer

Oncology, 2024

DOI 10.1159/000540517 PMID 39079501 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

Letrozole-induced reversible acute heart failure

Journal of Oncology Pharmacy Practice, 2024

DOI 10.1177/10781552241284908 PMID 39275843 2 atıf (OpenAlex) Kaynak: OpenAlex